Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR2 | P21802 | 6/20 | 0.63 |
| ▸ | FGFR4 | P22455 | 5/20 | 0.63 |
| ▸ | FGFR1 | P11362 | 5/20 | 0.63 |
| ▸ | FGFR3 | P22607 | 4/20 | 0.63 |
| ▸ | HDAC6 | Q9UBN7 | 8/20 | 0.63 |
| ▸ | GSK3A | P49840 | 1/20 | 0.52 |
| ▸ | GSK3B | P49841 | 1/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.51 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.51 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4493101 | 0.94 | HDAC6 (0.70) | FGFR2FGFR4FGFR1FGFR3HDAC6 | |
| SCHEMBL4491527 | 0.90 | HDAC6 (0.61) | FGFR2FGFR4FGFR1FGFR3HDAC6 | |
| SCHEMBL4485585 | 0.89 | FGFR2 (0.63) | FGFR2FGFR4FGFR1FGFR3HDAC6 | |
| SCHEMBL4490112 | 0.88 | FGFR1 (0.62) | FGFR2FGFR4FGFR1FGFR3HDAC6 | |
| SCHEMBL4500976 | 0.86 | HDAC6 (0.58) | FGFR2FGFR4FGFR1FGFR3HDAC6 | |
| SCHEMBL4482955 | 0.86 | HDAC6 (0.62) | FGFR2FGFR4FGFR1FGFR3HDAC6 | |
| SCHEMBL4491623 | 0.86 | FGFR4 (0.58) | FGFR2FGFR4FGFR1FGFR3HDAC6 | |
| SCHEMBL4483026 | 0.85 | FGFR4 (0.65) | FGFR2FGFR4FGFR1FGFR3HDAC6 | |
| SCHEMBL4487476 | 0.85 | HDAC6 (0.57) | FGFR2FGFR4FGFR1FGFR3HDAC6 | |
| SCHEMBL4492428 | 0.85 | HDAC6 (0.62) | FGFR2FGFR4FGFR1FGFR3HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7632854-B2 | Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | PFIZER ITALIA S.R.L. (IT) | 2009-12-15 | — | — | US | claimed |